Modus Therapeutics Holding Stock Net Income
| MODTX Stock | 0.35 0.03 9.37% |
Fundamental analysis of Modus Therapeutics allows traders to better anticipate movements in Modus Therapeutics' stock price by examining its financial health and performance throughout various phases of its business cycle.
Modus |
Modus Therapeutics Holding Company Net Income Analysis
Modus Therapeutics' Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.
Current Modus Therapeutics Net Income | (20.69 M) |
Most of Modus Therapeutics' fundamental indicators, such as Net Income, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Modus Therapeutics Holding is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Based on the recorded statements, Modus Therapeutics Holding reported net income of (20.69 Million). This is 106.06% lower than that of the Healthcare sector and 129.54% lower than that of the Biotechnology industry. The net income for all Sweden stocks is 103.62% higher than that of the company.
Modus Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Modus Therapeutics' direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Modus Therapeutics could also be used in its relative valuation, which is a method of valuing Modus Therapeutics by comparing valuation metrics of similar companies.Modus Therapeutics is currently under evaluation in net income category among its peers.
Modus Fundamentals
| Return On Equity | -1.22 | |||
| Return On Asset | -0.54 | |||
| Current Valuation | 32.01 M | |||
| Shares Outstanding | 16.1 M | |||
| Shares Owned By Insiders | 79.18 % | |||
| Price To Book | 5.78 X | |||
| EBITDA | (20.69 M) | |||
| Net Income | (20.69 M) | |||
| Book Value Per Share | 0.42 X | |||
| Cash Flow From Operations | (16.08 M) | |||
| Earnings Per Share | (1.57) X | |||
| Market Capitalization | 74.95 M | |||
| Total Asset | 21.19 M | |||
| Net Asset | 21.19 M |
About Modus Therapeutics Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Modus Therapeutics Holding's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Modus Therapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Modus Therapeutics Holding based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Modus Stock Analysis
When running Modus Therapeutics' price analysis, check to measure Modus Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Modus Therapeutics is operating at the current time. Most of Modus Therapeutics' value examination focuses on studying past and present price action to predict the probability of Modus Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Modus Therapeutics' price. Additionally, you may evaluate how the addition of Modus Therapeutics to your portfolios can decrease your overall portfolio volatility.